The Impact of COVID-19 is included in Liver Cancer Diagnostic Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Liver Cancer Diagnostic Trends and Forecast
The future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Liver Cancer Diagnostic by Segment
The study includes a forecast for the global liver cancer diagnostic by test type, end use, and region.
Liver Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:
• Laboratory Tests
• Imaging
• Endoscopy
• Biopsy
• Others
Liver Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & CRO Laboratories
Liver Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Liver Cancer Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies liver cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liver cancer diagnostic companies profiled in this report include-
• Abbott Laboratories
• F. Hoffmann-La Roche
• Qiagen
• Thermo Fisher Scientific
• Siemens Healthineers
Liver Cancer Diagnostic Market Insights
Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.
Within this market, hospitaland diagnostic laboratory will remain the largest segment over the forecast period.
North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.
Features of the Global Liver Cancer Diagnostic Market
Market Size Estimates: Liver cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Liver cancer diagnostic market size by test type, end use, and region in terms of value ($B).
Regional Analysis: Liver cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different test types, end uses, and regions for the liver cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the liver cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the liver cancer diagnostic market size?
Answer: The global liver cancer diagnostic market is expected to reach an estimated $11.0 billion by 2030.
Q2. What is the growth forecast for liver cancer diagnostic market?
Answer: The global liver cancer diagnostic market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the liver cancer diagnostic market?
Answer: The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
Q4. What are the major segments for liver cancer diagnostic market?
Answer: The future of the liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets.
Q5. Who are the key liver cancer diagnostic market companies?
Answer: Some of the key liver cancer diagnostic companies are as follows:
• Abbott Laboratories
• F. Hoffmann-La Roche
• Qiagen
• Thermo Fisher Scientific
• Siemens Healthineers
Q6. Which liver cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that laboratory test will remain the largest segment over the forecast period due to its rising preference among general public because of its precision and cost-effectiveness.
Q7. In liver cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare settings, rising adoption of healthcare insurance policies among the population, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the liver cancer diagnostic market by test type (laboratory tests, imaging, endoscopy, biopsy, and others), end use (hospitals & diagnostic laboratories, academic & research institutes, and pharmaceutical & CRO laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Liver Cancer Diagnostic Market, Liver Cancer Diagnostic Market Size, Liver Cancer Diagnostic Market Growth, Liver Cancer Diagnostic Market Analysis, Liver Cancer Diagnostic Market Report, Liver Cancer Diagnostic Market Share, Liver Cancer Diagnostic Market Trends, Liver Cancer Diagnostic Market Forecast, Liver Cancer Diagnostic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Liver Cancer Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Liver Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Liver Cancer Diagnostic Market by Test Type
3.3.1: Laboratory Tests
3.3.2: Imaging
3.3.3: Endoscopy
3.3.4: Biopsy
3.3.5: Others
3.4: Global Liver Cancer Diagnostic Market by End Use
3.4.1: Hospitals & Diagnostic Laboratories
3.4.2: Academic & Research Institutes
3.4.3: Pharmaceutical & CRO Laboratories
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Liver Cancer Diagnostic Market by Region
4.2: North American Liver Cancer Diagnostic Market
4.2.2: North American Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
4.3: European Liver Cancer Diagnostic Market
4.3.1: European Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
4.3.2: European Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
4.4: APAC Liver Cancer Diagnostic Market
4.4.1: APAC Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
4.4.2: APAC Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
4.5: ROW Liver Cancer Diagnostic Market
4.5.1: ROW Liver Cancer Diagnostic Market by Test Type: Laboratory Tests, Imaging, Endoscopy, Biopsy, and Others
4.5.2: ROW Liver Cancer Diagnostic Market by End Use: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, and Pharmaceutical & CRO Laboratories
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Test Type
6.1.2: Growth Opportunities for the Global Liver Cancer Diagnostic Market by End Use
6.1.3: Growth Opportunities for the Global Liver Cancer Diagnostic Market by Region
6.2: Emerging Trends in the Global Liver Cancer Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Liver Cancer Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Liver Cancer Diagnostic Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbott Laboratories
7.2: F. Hoffmann-La Roche
7.3: Qiagen
7.4: Thermo Fisher Scientific
7.5: Siemens Healthineers
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Liver Cancer Diagnostic Market Report.